Genesis Innovation Group‘s Cultivate(MD) Capital Fund II said that it has invested in Magnesium Development Company (MDC), a firm with a breakthrough magnesium (Mg) alloy technology for orthopedic use.
MDC designed its technology to combine the strength and handling properties of metal with complete, controllable absorption. Its magnesium alloy may be used in multiple applications to provide appropriate strength for a given indication while not interfering with imaging or creating the need for future hardware removal procedures, according to a statement from Genesis. The Holland, Mich.-based company’s devices will include interference screws for anterior cruciate ligament (ACL) repair, sports medicine anchors, various plates, screws, and wires addressing foot and ankle procedures, as well as trauma applications.
Registration is open for DeviceTalks Boston! Join us on June 5-6, 2019, as we explore the trends and technology that are shaping the future of the medical device industry.